Efficiency of new antimycobacterial preparation isofon in children and teenagers with tuberculosis

Z. I. Kryvasheyeva, P. S. Krivonos, A. S. Pozdnyakova, N. A. Emeljanova, A. M. Scrahina, N. S. Morozkina, Z. V. Lavor (Minsk, Belarus)

Source: Annual Congress 2004 - Management of tuberculosis
Session: Management of tuberculosis
Session type: Oral Presentation
Number: 3043
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Z. I. Kryvasheyeva, P. S. Krivonos, A. S. Pozdnyakova, N. A. Emeljanova, A. M. Scrahina, N. S. Morozkina, Z. V. Lavor (Minsk, Belarus). Efficiency of new antimycobacterial preparation isofon in children and teenagers with tuberculosis. Eur Respir J 2004; 24: Suppl. 48, 3043

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Detection of Mycobacterium tuberculosis in children during complex antimycobacterial therapy
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009

Effectiveness of treatment for MDR TB in children and adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007


Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges
Source: Eur Respir J 2016; 48: 938-943
Year: 2016


Structure of drug resistance of M. tuberculosis in children and adolescents with pulmonary TB
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002

Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources
Source: Eur Respir J 2006; 28: Suppl. 50, 28s
Year: 2006

New and repurposed TB drugs use in children and adolescents with M/XDR-TB
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017



Experience of using Diaskintest by tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012


Errors in the diagnostics of tuberculosis in children
Source: Eur Respir J 2006; 28: Suppl. 50, 23s
Year: 2006

Revealing and prophylaxis of a tuberculosis at HIV-infected persons
Source: Eur Respir J 2006; 28: Suppl. 50, 22s
Year: 2006

Population-based survey of antimycobacterial drug use among patients with non-tuberculosis mycobacterial pulmonary disease
Source: ERJ Open Res, 6 (1) 00097-2019; 10.1183/23120541.00097-2019
Year: 2020



Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update
Source: Eur Respir J, 57 (5) 2002483; 10.1183/13993003.02483-2020
Year: 2021



Aspects of tuberculosis associated with HIV in children
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003

New approaches to MDR/XDR TB chemotherapy in children and adolescents
Source: International Congress 2019 – Tuberculosis: treatment and management
Year: 2019

Active tuberculosis case-finding among drug users and homeless persons: after the outbreak
Source: Eur Respir J 2016; 48: 269-271
Year: 2016


Challenges in TB treatment in children
Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults
Year: 2014

The description and methods of pulmonary tuberculosis detection in children of older age and teenagers
Source: Eur Respir J 2007; 30: Suppl. 51, 412s
Year: 2007

Bacteriological evaluation for diagnosis of tuberculosis in children
Source: Annual Congress 2009 - Tuberculosis at different age groups
Year: 2009


Peculiarities of tuberculosis case-finding in migrants
Source: Eur Respir J 2004; 24: Suppl. 48, 420s
Year: 2004